Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 183

1.

Preanalytics and Precision Pathology: Pathology Practices to Ensure Molecular Integrity of Cancer Patient Biospecimens for Precision Medicine.

Compton CC, Robb JA, Anderson MW, Berry AB, Birdsong GG, Bloom KJ, Branton PA, Crothers JW, Cushman-Vokoun AM, Hicks DG, Khoury JD, Laser J, Marshall CB, Misialek MJ, Natale KE, Nowak JA, Olson D, Pfeifer JD, Schade A, Vance GH, Walk EE, Yohe SL.

Arch Pathol Lab Med. 2019 Nov;143(11):1346-1363. doi: 10.5858/arpa.2019-0009-SA. Epub 2019 Jul 22.

PMID:
31329478
2.

The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging.

Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP.

CA Cancer J Clin. 2017 Mar;67(2):93-99. doi: 10.3322/caac.21388. Epub 2017 Jan 17.

3.

A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803.

Niedzwiecki D, Hasson RM, Lenz HJ, Ye C, Redston M, Ogino S, Fuchs CS, Compton CC, Mayer RJ, Goldberg RM, Colacchio TA, Saltz LB, Warren RS, Bertagnolli MM.

Oncologist. 2017 Jan;22(1):107-114. doi: 10.1634/theoncologist.2016-0215. Epub 2016 Nov 7.

4.

The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: Analysis of the National Cancer Data Base.

Asare EA, Compton CC, Hanna NN, Kosinski LA, Washington MK, Kakar S, Weiser MR, Overman MJ.

Cancer. 2016 Jan 15;122(2):213-21. doi: 10.1002/cncr.29744. Epub 2015 Oct 27.

5.

A Novel Approach to High-Quality Postmortem Tissue Procurement: The GTEx Project.

Carithers LJ, Ardlie K, Barcus M, Branton PA, Britton A, Buia SA, Compton CC, DeLuca DS, Peter-Demchok J, Gelfand ET, Guan P, Korzeniewski GE, Lockhart NC, Rabiner CA, Rao AK, Robinson KL, Roche NV, Sawyer SJ, Segrè AV, Shive CE, Smith AM, Sobin LH, Undale AH, Valentino KM, Vaught J, Young TR, Moore HM; GTEx Consortium.

Biopreserv Biobank. 2015 Oct;13(5):311-9. doi: 10.1089/bio.2015.0032.

6.

The national biomarker development alliance: confronting the poor productivity of biomarker research and development.

Poste G, Compton CC, Barker AD.

Expert Rev Mol Diagn. 2015 Feb;15(2):211-8. doi: 10.1586/14737159.2015.974561. Epub 2014 Nov 25. Review.

PMID:
25420639
7.

The National Biomarker Development Alliance accelerating the translation of biomarkers to the clinic.

Barker AD, Compton CC, Poste G.

Biomark Med. 2014;8(6):873-6. doi: 10.2217/bmm.14.52. No abstract available.

8.

Meeting research needs with postmortem biospecimen donation: summary of recommendations for postmortem recovery of normal human biospecimens for research.

Mucci NR, Moore HM, Brigham LE, Goldthwaite CA, Little AR, Lockhart NC, Scott MP, Struewing JP, Vincent SL, Compton CC; cancer Human Biobank (caHUB) Acquisition of Normal Tissue Subgroup, National Cancer Institute.

Biopreserv Biobank. 2013 Apr;11(2):77-82. doi: 10.1089/bio.2012.0063. Erratum in: Biopreserv Biobank. 2013 Jun;11(3):191.

PMID:
24845428
9.

Association of TP53 mutational status and gender with survival after adjuvant treatment for stage III colon cancer: results of CALGB 89803.

Warren RS, Atreya CE, Niedzwiecki D, Weinberg VK, Donner DB, Mayer RJ, Goldberg RM, Compton CC, Zuraek MB, Ye C, Saltz LB, Bertagnolli MM.

Clin Cancer Res. 2013 Oct 15;19(20):5777-87. doi: 10.1158/1078-0432.CCR-13-0351. Epub 2013 Aug 27.

10.

Intersection of biobanking and clinical care: should discrepant diagnoses and pathological findings be returned to research participants?

Lockhart NC, Yassin R, Weil CJ, Compton CC.

Genet Med. 2012 Apr;14(4):417-23. doi: 10.1038/gim.2012.11. Epub 2012 Feb 16.

PMID:
22344228
11.

Biospecimens and biorepositories: from afterthought to science.

Vaught JB, Henderson MK, Compton CC.

Cancer Epidemiol Biomarkers Prev. 2012 Feb;21(2):253-5. doi: 10.1158/1055-9965.EPI-11-1179.

12.

Why a pathology image should not be considered as a radiology image.

Hipp JD, Fernandez A, Compton CC, Balis UJ.

J Pathol Inform. 2011;2:26. doi: 10.4103/2153-3539.82051. Epub 2011 Jun 14. No abstract available.

13.

Microsatellite instability and loss of heterozygosity at chromosomal location 18q: prospective evaluation of biomarkers for stages II and III colon cancer--a study of CALGB 9581 and 89803.

Bertagnolli MM, Redston M, Compton CC, Niedzwiecki D, Mayer RJ, Goldberg RM, Colacchio TA, Saltz LB, Warren RS.

J Clin Oncol. 2011 Aug 10;29(23):3153-62. doi: 10.1200/JCO.2010.33.0092. Epub 2011 Jul 11.

14.

Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581.

Niedzwiecki D, Bertagnolli MM, Warren RS, Compton CC, Kemeny NE, Benson AB 3rd, Eckhardt SG, Alberts S, Porjosh GN, Kerr DJ, Fields A, Rougier P, Pipas JM, Schwartz JH, Atkins J, O'Rourke M, Perry MC, Goldberg RM, Mayer RJ, Colacchio TA.

J Clin Oncol. 2011 Aug 10;29(23):3146-52. doi: 10.1200/JCO.2010.32.5357. Epub 2011 Jul 11.

15.

Digital slide repositories for publications: lessons learned from the microarray community.

Hipp JD, Lucas DR, Emmert-Buck MR, Compton CC, Balis UJ.

Am J Surg Pathol. 2011 Jun;35(6):783-6. doi: 10.1097/PAS.0b013e31821946b6. No abstract available.

PMID:
21552111
16.

International approaches to advancing biospecimen science.

Moore HM, Compton CC, Alper J, Vaught JB.

Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):729-32. doi: 10.1158/1055-9965.EPI-11-0021. Epub 2011 Mar 23.

17.

Before you analyze a human specimen, think quality, variability, and bias.

Lim MD, Dickherber A, Compton CC.

Anal Chem. 2011 Jan 1;83(1):8-13. doi: 10.1021/ac1018974. Epub 2010 Nov 29. Review.

18.

TNM seventh edition: what's new, what's changed: communication from the International Union Against Cancer and the American Joint Committee on Cancer.

Sobin LH, Compton CC.

Cancer. 2010 Nov 15;116(22):5336-9. doi: 10.1002/cncr.25537. No abstract available.

19.

Making economic sense of cancer biospecimen banks.

Compton CC.

Clin Transl Sci. 2009 Jun;2(3):172-4. doi: 10.1111/j.1752-8062.2008.00108.x. No abstract available.

20.

International network of cancer genome projects.

International Cancer Genome Consortium, Hudson TJ, Anderson W, Artez A, Barker AD, Bell C, Bernabé RR, Bhan MK, Calvo F, Eerola I, Gerhard DS, Guttmacher A, Guyer M, Hemsley FM, Jennings JL, Kerr D, Klatt P, Kolar P, Kusada J, Lane DP, Laplace F, Youyong L, Nettekoven G, Ozenberger B, Peterson J, Rao TS, Remacle J, Schafer AJ, Shibata T, Stratton MR, Vockley JG, Watanabe K, Yang H, Yuen MM, Knoppers BM, Bobrow M, Cambon-Thomsen A, Dressler LG, Dyke SO, Joly Y, Kato K, Kennedy KL, Nicolás P, Parker MJ, Rial-Sebbag E, Romeo-Casabona CM, Shaw KM, Wallace S, Wiesner GL, Zeps N, Lichter P, Biankin AV, Chabannon C, Chin L, Clément B, de Alava E, Degos F, Ferguson ML, Geary P, Hayes DN, Hudson TJ, Johns AL, Kasprzyk A, Nakagawa H, Penny R, Piris MA, Sarin R, Scarpa A, Shibata T, van de Vijver M, Futreal PA, Aburatani H, Bayés M, Botwell DD, Campbell PJ, Estivill X, Gerhard DS, Grimmond SM, Gut I, Hirst M, López-Otín C, Majumder P, Marra M, McPherson JD, Nakagawa H, Ning Z, Puente XS, Ruan Y, Shibata T, Stratton MR, Stunnenberg HG, Swerdlow H, Velculescu VE, Wilson RK, Xue HH, Yang L, Spellman PT, Bader GD, Boutros PC, Campbell PJ, Flicek P, Getz G, Guigó R, Guo G, Haussler D, Heath S, Hubbard TJ, Jiang T, Jones SM, Li Q, López-Bigas N, Luo R, Muthuswamy L, Ouellette BF, Pearson JV, Puente XS, Quesada V, Raphael BJ, Sander C, Shibata T, Speed TP, Stein LD, Stuart JM, Teague JW, Totoki Y, Tsunoda T, Valencia A, Wheeler DA, Wu H, Zhao S, Zhou G, Stein LD, Guigó R, Hubbard TJ, Joly Y, Jones SM, Kasprzyk A, Lathrop M, López-Bigas N, Ouellette BF, Spellman PT, Teague JW, Thomas G, Valencia A, Yoshida T, Kennedy KL, Axton M, Dyke SO, Futreal PA, Gerhard DS, Gunter C, Guyer M, Hudson TJ, McPherson JD, Miller LJ, Ozenberger B, Shaw KM, Kasprzyk A, Stein LD, Zhang J, Haider SA, Wang J, Yung CK, Cros A, Liang Y, Gnaneshan S, Guberman J, Hsu J, Bobrow M, Chalmers DR, Hasel KW, Joly Y, Kaan TS, Kennedy KL, Knoppers BM, Lowrance WW, Masui T, Nicolás P, Rial-Sebbag E, Rodriguez LL, Vergely C, Yoshida T, Grimmond SM, Biankin AV, Bowtell DD, Cloonan N, deFazio A, Eshleman JR, Etemadmoghadam D, Gardiner BB, Kench JG, Scarpa A, Sutherland RL, Tempero MA, Waddell NJ, Wilson PJ, McPherson JD, Gallinger S, Tsao MS, Shaw PA, Petersen GM, Mukhopadhyay D, Chin L, DePinho RA, Thayer S, Muthuswamy L, Shazand K, Beck T, Sam M, Timms L, Ballin V, Lu Y, Ji J, Zhang X, Chen F, Hu X, Zhou G, Yang Q, Tian G, Zhang L, Xing X, Li X, Zhu Z, Yu Y, Yu J, Yang H, Lathrop M, Tost J, Brennan P, Holcatova I, Zaridze D, Brazma A, Egevard L, Prokhortchouk E, Banks RE, Uhlén M, Cambon-Thomsen A, Viksna J, Ponten F, Skryabin K, Stratton MR, Futreal PA, Birney E, Borg A, Børresen-Dale AL, Caldas C, Foekens JA, Martin S, Reis-Filho JS, Richardson AL, Sotiriou C, Stunnenberg HG, Thoms G, van de Vijver M, van't Veer L, Calvo F, Birnbaum D, Blanche H, Boucher P, Boyault S, Chabannon C, Gut I, Masson-Jacquemier JD, Lathrop M, Pauporté I, Pivot X, Vincent-Salomon A, Tabone E, Theillet C, Thomas G, Tost J, Treilleux I, Calvo F, Bioulac-Sage P, Clément B, Decaens T, Degos F, Franco D, Gut I, Gut M, Heath S, Lathrop M, Samuel D, Thomas G, Zucman-Rossi J, Lichter P, Eils R, Brors B, Korbel JO, Korshunov A, Landgraf P, Lehrach H, Pfister S, Radlwimmer B, Reifenberger G, Taylor MD, von Kalle C, Majumder PP, Sarin R, Rao TS, Bhan MK, Scarpa A, Pederzoli P, Lawlor RA, Delledonne M, Bardelli A, Biankin AV, Grimmond SM, Gress T, Klimstra D, Zamboni G, Shibata T, Nakamura Y, Nakagawa H, Kusada J, Tsunoda T, Miyano S, Aburatani H, Kato K, Fujimoto A, Yoshida T, Campo E, López-Otín C, Estivill X, Guigó R, de Sanjosé S, Piris MA, Montserrat E, González-Díaz M, Puente XS, Jares P, Valencia A, Himmelbauer H, Quesada V, Bea S, Stratton MR, Futreal PA, Campbell PJ, Vincent-Salomon A, Richardson AL, Reis-Filho JS, van de Vijver M, Thomas G, Masson-Jacquemier JD, Aparicio S, Borg A, Børresen-Dale AL, Caldas C, Foekens JA, Stunnenberg HG, van't Veer L, Easton DF, Spellman PT, Martin S, Barker AD, Chin L, Collins FS, Compton CC, Ferguson ML, Gerhard DS, Getz G, Gunter C, Guttmacher A, Guyer M, Hayes DN, Lander ES, Ozenberger B, Penny R, Peterson J, Sander C, Shaw KM, Speed TP, Spellman PT, Vockley JG, Wheeler DA, Wilson RK, Hudson TJ, Chin L, Knoppers BM, Lander ES, Lichter P, Stein LD, Stratton MR, Anderson W, Barker AD, Bell C, Bobrow M, Burke W, Collins FS, Compton CC, DePinho RA, Easton DF, Futreal PA, Gerhard DS, Green AR, Guyer M, Hamilton SR, Hubbard TJ, Kallioniemi OP, Kennedy KL, Ley TJ, Liu ET, Lu Y, Majumder P, Marra M, Ozenberger B, Peterson J, Schafer AJ, Spellman PT, Stunnenberg HG, Wainwright BJ, Wilson RK, Yang H.

Nature. 2010 Apr 15;464(7291):993-8. doi: 10.1038/nature08987. Erratum in: Nature. 2010 Jun 17;465(7300):966. Himmelbaue, Heinz [corrected to Himmelbauer, Heinz]; Gardiner, Brooke A [corrected to Gardiner, Brooke B]; Cross, Anthony [corrected to Cros, Anthony].

21.

Protocol for the examination of specimens from patients with carcinoma of the distal extrahepatic bile ducts.

Washington MK, Berlin J, Branton PA, Burgart LJ, Carter DK, Compton CC, Fitzgibbons PL, Frankel WL, Jessup JM, Kakar S, Minsky B, Nakhleh RE, Vauthey JN; Members of the Cancer Committee, College of American Pathologists.

Arch Pathol Lab Med. 2010 Apr;134(4):e8-13. doi: 10.1043/1543-2165-134.4.e8. No abstract available.

PMID:
20367298
22.

Protocol for the examination of specimens from patients with carcinoma of the perihilar bile ducts.

Washington MK, Berlin J, Branton PA, Burgart LJ, Carter DK, Compton CC, Fitzgibbons PL, Frankel WL, Jessup JM, Kakar S, Minsky B, Nakhleh RE, Vauthey JN; Members of the Cancer Committee, College of American Pathologists.

Arch Pathol Lab Med. 2010 Apr;134(4):e19-24. doi: 10.1043/1543-2165-134.4.e19. No abstract available.

PMID:
20367295
23.

Protocol for the examination of specimens from patients with carcinoma of the intrahepatic bile ducts.

Washington MK, Berlin J, Branton PA, Burgart LJ, Carter DK, Compton CC, Frankel WL, Jessup JM, Kakar S, Minsky B, Nakhleh RE, Vauthey JN; Members of the Cancer Committee, College of American Pathologists.

Arch Pathol Lab Med. 2010 Apr;134(4):e14-8. doi: 10.1043/1543-2165-134.4.e14. No abstract available.

PMID:
20367294
24.

The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.

Edge SB, Compton CC.

Ann Surg Oncol. 2010 Jun;17(6):1471-4. doi: 10.1245/s10434-010-0985-4.

PMID:
20180029
25.

Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the stomach.

Washington MK, Tang LH, Berlin J, Branton PA, Burgart LJ, Carter DK, Compton CC, Fitzgibbons PL, Frankel WL, Jessup JM, Kakar S, Minsky B, Nakhleh RE; Members of the Cancer Committee, College of American Pathologists.

Arch Pathol Lab Med. 2010 Feb;134(2):187-91. doi: 10.1043/1543-2165-134.2.187. No abstract available.

PMID:
20121605
26.

Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the small intestine and ampulla.

Washington MK, Tang LH, Berlin J, Branton PA, Burgart LJ, Carter DK, Compton CC, Fitzgibbons PL, Frankel WL, Jessup JM, Kakar S, Minsky B, Nakhleh RE; Members of the Cancer Committee, College of American Pathologists.

Arch Pathol Lab Med. 2010 Feb;134(2):181-6. doi: 10.1043/1543-2165-134.2.181. No abstract available.

PMID:
20121604
27.

Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the colon and rectum.

Washington MK, Tang LH, Berlin J, Branton PA, Burgart LJ, Carter DK, Compton CC, Fitzgibbons PL, Frankel WL, Jessup JM, Kakar S, Minsky B, Nakhleh RE; Members of the Cancer Committee, College of American Pathologists.

Arch Pathol Lab Med. 2010 Feb;134(2):176-80. doi: 10.1043/1543-2165-134.2.176. No abstract available.

PMID:
20121603
28.

Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the appendix.

Washington MK, Tang LH, Berlin J, Branton PA, Burgart LJ, Carter DK, Compton CC, Fitzgibbons PL, Frankel WL, Jessup JM, Kakar S, Minsky B, Nakhleh RE; Members of the Cancer Committee, College of American Pathologists.

Arch Pathol Lab Med. 2010 Feb;134(2):171-5. doi: 10.1043/1543-2165-134.2.171. No abstract available.

PMID:
20121602
29.

Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum.

Washington MK, Berlin J, Branton P, Burgart LJ, Carter DK, Fitzgibbons PL, Halling K, Frankel W, Jessup J, Kakar S, Minsky B, Nakhleh R, Compton CC; Members of the Cancer Committee, College of American Pathologists.

Arch Pathol Lab Med. 2009 Oct;133(10):1539-51. doi: 10.1043/1543-2165-133.10.1539. No abstract available.

30.

2009 Biospecimen research network symposium: advancing cancer research through biospecimen science.

Moore HM, Compton CC, Lim MD, Vaught J, Christiansen KN, Alper J.

Cancer Res. 2009 Sep 1;69(17):6770-2. doi: 10.1158/0008-5472.CAN-09-1795. Epub 2009 Aug 25.

31.

The surgical specimen is the personalized part of personalized cancer medicine.

Compton CC.

Ann Surg Oncol. 2009 Aug;16(8):2079-80. doi: 10.1245/s10434-009-0526-1. Epub 2009 May 27. No abstract available.

32.

p27Kip1 in stage III colon cancer: implications for outcome following adjuvant chemotherapy in cancer and leukemia group B protocol 89803.

Bertagnolli MM, Warren RS, Niedzwiecki D, Mueller E, Compton CC, Redston M, Hall M, Hahn HP, Jewell SD, Mayer RJ, Goldberg RM, Saltz LB, Loda M.

Clin Cancer Res. 2009 Mar 15;15(6):2116-22. doi: 10.1158/1078-0432.CCR-08-2674. Epub 2009 Mar 10.

33.

Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803.

Bertagnolli MM, Niedzwiecki D, Compton CC, Hahn HP, Hall M, Damas B, Jewell SD, Mayer RJ, Goldberg RM, Saltz LB, Warren RS, Redston M.

J Clin Oncol. 2009 Apr 10;27(11):1814-21. doi: 10.1200/JCO.2008.18.2071. Epub 2009 Mar 9.

34.

Documenting biospecimen conditions in reports of studies.

Robb JA, Moore HM, Compton CC.

JAMA. 2008 Aug 13;300(6):650-1; author reply 651. doi: 10.1001/jama.300.6.650-c. No abstract available.

PMID:
18698060
35.

Protocol for the examination of specimens from patients with primary carcinomas of the colon and rectum.

Washington MK, Berlin J, Branton PA, Burgart LJ, Carter DK, Fitzgibbons PL, Frankel WL, Jessup JM, Kakar S, Minsky B, Nakhleh RE, Compton CC; Cancer Committee, College of American Pathologists.

Arch Pathol Lab Med. 2008 Jul;132(7):1182-93. doi: 10.1043/1543-2165(2008)132[1182:PFTEOS]2.0.CO;2. No abstract available. Erratum in: Arch Pathol Lab Med. 2008 Sep;132(9):1384.

PMID:
18605770
36.

Tissue-based research in kidney cancer: current challenges and future directions.

Signoretti S, Bratslavsky G, Waldman FM, Reuter VE, Haaga J, Merino M, Thomas GV, Pins MR, Libermann T, Gillespie J, Tomaszewski JE, Compton CC, Hruszkewycz A, Linehan WM, Atkins MB.

Clin Cancer Res. 2008 Jun 15;14(12):3699-705. doi: 10.1158/1078-0432.CCR-07-4733. Review.

37.

Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy.

Zlobec I, Vuong T, Compton CC, Lugli A, Michel RP, Hayashi S, Jass JR.

Br J Cancer. 2008 Jan 29;98(2):450-6. doi: 10.1038/sj.bjc.6604172. Epub 2008 Jan 8.

38.

Newer pathologic assessment techniques for colorectal carcinoma.

Turner RR, Li C, Compton CC.

Clin Cancer Res. 2007 Nov 15;13(22 Pt 2):6871s-6s. Review.

39.

Optimal pathologic staging: defining stage II disease.

Compton CC.

Clin Cancer Res. 2007 Nov 15;13(22 Pt 2):6862s-70s. Review.

40.

New approaches to assessing and treating early-stage colon and rectal cancer: summary statement from 2007 Santa Monica Conference.

Rosen LS, Bilchik AJ, Beart RW Jr, Benson AB 3rd, Chang KJ, Compton CC, Grothey A, Haller DG, Ko CY, Lynch PM, Nelson H, Stamos MJ, Turner RR, Willett CG.

Clin Cancer Res. 2007 Nov 15;13(22 Pt 2):6853s-6s.

41.

Protocol for the examination of specimens from patients with invasive carcinomas of the appendix.

Misdraji J, Oliva E, Goldblum JR, Lauwers GY, Compton CC; Members of the Cancer Committee, College of American Pathologists.

Arch Pathol Lab Med. 2006 Oct;130(10):1433-9. No abstract available.

PMID:
17090183
42.

Scoring of p53, VEGF, Bcl-2 and APAF-1 immunohistochemistry and interobserver reliability in colorectal cancer.

Zlobec I, Steele R, Michel RP, Compton CC, Lugli A, Jass JR.

Mod Pathol. 2006 Sep;19(9):1236-42. Epub 2006 Jun 2.

43.
44.

Analysis of micrometastatic disease in sentinel lymph nodes from resectable colon cancer: results of Cancer and Leukemia Group B Trial 80001.

Redston M, Compton CC, Miedema BW, Niedzwiecki D, Dowell JM, Jewell SD, Fleshman JM, Bem J, Mayer RJ, Bertagnolli MM; Leukemia Group B Trial 80001.

J Clin Oncol. 2006 Feb 20;24(6):878-83. Epub 2006 Jan 17.

PMID:
16418493
46.

VEGF as a predictive marker of rectal tumor response to preoperative radiotherapy.

Zlobec I, Steele R, Compton CC.

Cancer. 2005 Dec 1;104(11):2517-21.

47.
48.

The staging of colorectal cancer: 2004 and beyond.

Compton CC, Greene FL.

CA Cancer J Clin. 2004 Nov-Dec;54(6):295-308. Review.

50.

Protocol for the examination of specimens from patients with melanoma of the skin.

Compton CC, Barnhill R, Wick MR, Balch C; Members of the Cancer Committee, College of American Pathologists.

Arch Pathol Lab Med. 2003 Oct;127(10):1253-62. No abstract available.

PMID:
14521470

Supplemental Content

Loading ...
Support Center